Systematic synthesis of novel phosphoglycolipid analogues as potential agonists of GPR55

被引：4

作者：

Abe, Junpei ^{[1
]}

Guy, Adam T. ^{[2
]}

Ding, Feiqing ^{[3
]}

Greimel, Peter ^{[2
]}

Hirabayashi, Yoshio ^{[4
]}

Kamiguchi, Hiroyuki ^{[2
]}

Ito, Yukishige ^{[1
,4
]}

机构：

[1] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan

[2] RIKEN, Ctr Brain Res, Wako, Saitama 3510198, Japan

[3] Sun Yat Sen Univ, Sch Pharmaceut Sci Shenzhen, Guangzhou 510275, Peoples R China

[4] RIKEN Cluster Pioneering Res, Wako, Saitama 3510198, Japan

来源：

ORGANIC & BIOMOLECULAR CHEMISTRY | 2020年 / 18卷 / 41期

关键词：

COUPLED RECEPTOR GPR55; CANNABINOID RECEPTOR; SIGNALING PATHWAYS; DRUG DISCOVERY; LYSOPHOSPHATIDYLINOSITOL; IDENTIFICATION; CANCER; LIGAND; CELLS; ISLETS;

D O I：

10.1039/d0ob01756f

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

Rhodopsin-like G protein-coupled receptor (GPCR) GPR55 is attracting attention as a pharmaceutical target, because of its relationship with various physiological and pathological events. Although GPR55 was initially deorphanized as a cannabinoid receptor, lysophosphatidylinositol (LPI) is now widely perceived to be an endogenous ligand of GPR55. Recently, lysophosphatidyl-beta-d-glucoside (LPGlc) has been found to act on GPR55 to repel dorsal root ganglion (DRG) neurons. In this study, we designed and synthesized various LPGlc analogues having the squaryldiamide group as potential agonists of GPR55. By the axon turning assay, several analogues exhibited similar activities to that of LPGlc. These results will provide valuable information for understanding the mode of action of LPGlc and its analogues and for the discovery of potent and selective antagonists or agonists of GPR55.

引用

页码：8467 / 8473

页数：7

共 50 条

[21] Specificity of GPR55 agonists and antagonist in the regulation of calcium handling and insulin secretion by mouse islets
Song, S.
Liu, B.
Bowe, J. E.
Baker, D.
Jones, P. M.
Persaud, S. J.
DIABETIC MEDICINE, 2014, 31 : 32 - 32
[22] Discovery of Novel Peptide Antagonists Targeting GPR55 for Liver Inflammation and Fibrosis
Shi, Zihan
Liu, Xianyan
Wu, Shuohan
Song, Nazi
Tang, Qinglin
Li, Haonan
Luo, Suijia
Chan, Albert S. C.
Cai, Xiaoqing
Liu, Han
Jiang, Xianxing
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (14) : 12085 - 12098
[23] Potent and selective N-(4-sulfamoylphenyl)thiourea-based GPR55 agonists
Yrjola, Sari
Parkkari, Teija
Navia-Paldanius, Dina
Laitinen, Tuomo
Kaczor, Agnieszka A.
Kokkola, Tarja
Adusei-Mensah, Frank
Savinainen, Juha R.
Laitinen, Jarmo T.
Poso, Antti
Alexander, Amy
Penman, June
Stott, Lisa
Anskat, Marie
Irving, Andrew J.
Nevalainen, Tapio J.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 107 : 119 - 132
[24] Novel Potent and Selective Agonists of the GPR55 Receptor Based on the 3-Benzylquinolin-2(1H)-One Scaffold
Ceni, Costanza
Benko, Michael J.
Mohamed, Kawthar A.
Poli, Giulio
Di Stefano, Miriana
Tuccinardi, Tiziano
Digiacomo, Maria
Valoti, Massimo
Laprairie, Robert B.
Macchia, Marco
Bertini, Simone
PHARMACEUTICALS, 2022, 15 (07)
[25] The L-α-Lysophosphatidylinositol/GPR55 System and Its Potential Role in Human Obesity
Maria Moreno-Navarrete, Jose
Catalan, Victoria
Whyte, Lauren
Diaz-Arteaga, Adenis
Vazquez-Martinez, Rafael
Rotellar, Fernando
Guzman, Rocio
Gomez-Ambrosi, Javier
Pulido, Marina R.
Russell, Wendy R.
Imbernon, Monica
Ross, Ruth A.
Malagon, Maria M.
Dieguez, Carlos
Manuel Fernandez-Real, Jose
Fruehbeck, Gema
Nogueiras, Ruben
DIABETES, 2012, 61 (02) : 281 - 291
[26] GPR55: A novel cannabinoid receptor involved in the regulation of osteoclast function and bone mass
Whyte, L.
Ryberg, E.
Sims, N. A.
Ridge, S.
Mackie, K.
Greasley, P.
Ross, R. A.
Rogers, M. J.
BONE, 2009, 44 : S138 - S138
[27] Lipid bilayer molecular dynamics study of lipid-derived agonists of the putative cannabinoid receptor, GPR55
Kotsikorou, Eyangelia
Lynch, Diane L.
Abood, Mary E.
Reggio, Patricia H.
CHEMISTRY AND PHYSICS OF LIPIDS, 2011, 164 (02) : 131 - 143
[28] Novel protective effect of O-1602 and abnormal cannabidiol, GPR55 agonists, on ER stress-induced apoptosis in pancreatic β-cells
Vong, Chi Teng
Tseng, Hisa Hui Ling
Kwan, Yiu Wa
Lee, Simon Ming-Yuen
Hoi, Maggie Pui Man
BIOMEDICINE & PHARMACOTHERAPY, 2019, 111 : 1176 - 1186
[29] Potential Metabolic and Behavioural Roles of the Putative Endo-cannabinoid Receptors GPR18, GPR55 and GPR119 in Feeding
Ramirez-Orozco, Ricardo E.
Garcia-Ruiz, Ricardo
Morales, Paula
Villalon, Carlos M.
Rafael Villafan-Bernal, J.
Marichal-Cancino, Bruno A.
CURRENT NEUROPHARMACOLOGY, 2019, 17 (10) : 947 - 960
[30] The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation
Pineiro, R.
Maffucci, T.
Falasca, M.
ONCOGENE, 2011, 30 (02) : 142 - 152

← 1 2 3 4 5 →